TA
GILD icon

Thor Advisors’s Gilead Sciences GILD Stock Holding History

Thor Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$21K Buy
+275
New +$19K 1.1% 4
2019
Q4 		– Sell
-13,263
Closed -$841K – 100
2019
Q3 		$841K Buy
+13,263
New +$867K 0.96% 16

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Thor Advisors's GILD Position: Q1 2020 in Review

Thor Advisors opened a new position in Gilead Sciences (GILD) in Q1 2020: 275 shares worth $21K. The stake represents 1.1% of the portfolio and ranks #4 among its holdings. This is a return to the name: Thor Advisors previously reported a position in GILD as recently as Q3 2019.

Thor Advisors first reported a position in GILD in Q3 2019 and has held it in 2 quarters since. The position peaked at $841K in Q3 2019. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • Thor Advisors held 275 shares of Gilead Sciences worth $21K as of Q1 2020.
  • Gilead Sciences was a new Thor Advisors position in Q1 2020.
  • Gilead Sciences made up 1.1% of Thor Advisors's portfolio in Q1 2020, its #4 holding.
  • Thor Advisors first reported a position in Gilead Sciences in Q3 2019 and has held it in 2 quarters since.
  • Thor Advisors's Gilead Sciences position peaked at $841K in Q3 2019.
  • 1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Thor Advisors's 13F filing for Q1 2020, filed 18 May 2020.